Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 11.37% is 366% above its 5-year average of -4.28%, near the high end of its 5-year range (-35.50%–11.77%).
As of the fiscal period ended Saturday, June 27, 2026. 30.18% above its 12-month average of 8.73%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-27): 11.37%.
RETURN ON INVESTED CAPITAL (ROIC)
11.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
8.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
0.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-4.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+30.18%
CURRENT VS 3Y AVG
+2722.10%
CURRENT VS 5Y AVG
+365.58%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 759 covered companies
CURRENT VS SECTOR MEDIAN
+133.35%
vs the sector median at left
Bioventus Inc.
Market Cap
$900.08M
Return on Invested Capital (ROIC)
11.37%
TTM Avg
8.73%
3Y Avg
0.40%
5Y Avg
-4.28%
Market Cap
$886.94M
Return on Invested Capital (ROIC)
54.39%
TTM Avg
-47.91%
3Y Avg
-50.01%
5Y Avg
-47.22%
Market Cap
$915.31M
Return on Invested Capital (ROIC)
4.96%
TTM Avg
4.19%
3Y Avg
3.59%
5Y Avg
3.20%
Market Cap
$922.20M
Return on Invested Capital (ROIC)
-66.23%
TTM Avg
-66.23%
3Y Avg
-66.23%
5Y Avg
-66.23%
Market Cap
$870.34M
Return on Invested Capital (ROIC)
-25.25%
TTM Avg
-75.69%
3Y Avg
-67.13%
5Y Avg
-61.15%
Market Cap
$930.92M
Return on Invested Capital (ROIC)
-46.54%
TTM Avg
-25.88%
3Y Avg
-39.60%
5Y Avg
-39.60%
Market Cap
$867.56M
Return on Invested Capital (ROIC)
18.72%
TTM Avg
24.77%
3Y Avg
-14.92%
5Y Avg
-18.89%
Market Cap
$863.04M
Return on Invested Capital (ROIC)
-7.88%
TTM Avg
-13.88%
3Y Avg
-23.54%
5Y Avg
-23.72%
Market Cap
$938.31M
Return on Invested Capital (ROIC)
-50.77%
TTM Avg
-47.91%
3Y Avg
-50.09%
5Y Avg
-281.80%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bioventus Inc. (BVS) | $900.08M | 11.37% | 8.73% | 0.40% | -4.28% |
| Arbutus Biopharma Corp (ABUS)vs › | $886.94M | 54.39% | -47.91% | -50.01% | -47.22% |
| HealthStream, Inc. (HSTM)vs › | $915.31M | 4.96% | 4.19% | 3.59% | 3.20% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $922.20M | -66.23% | -66.23% | -66.23% | -66.23% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $870.34M | -25.25% | -75.69% | -67.13% | -61.15% |
| CeriBell, Inc. (CBLL)vs › | $930.92M | -46.54% | -25.88% | -39.60% | -39.60% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $867.56M | 18.72% | 24.77% | -14.92% | -18.89% |
| SI-BONE, Inc. (SIBN)vs › | $863.04M | -7.88% | -13.88% | -23.54% | -23.72% |
| MoonLake Immunotherapeutics (MLTX)vs › | $938.31M | -50.77% | -47.91% | -50.09% | -281.80% |
| QuidelOrtho Corporation (QDEL)vs › | $860.57M | -16.05% | -26.23% | -9.21% | 8.44% |
ROIC
11.4%
ROE
23.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-27 | 11.37% |
| 2026-03-28 | 11.77% |
| 2025-12-31 | 10.58% |
| 2025-09-27 | 6.48% |
| 2025-06-28 | 3.47% |
| 2025-03-29 | -2.61% |
| 2024-12-31 | -2.66% |
| 2024-09-28 | -3.57% |
| 2024-06-29 | -3.83% |
| 2024-03-30 | 2.32% |
| 2023-12-31 | -12.32% |
| 2023-09-30 | -16.17% |
| 2023-07-01 | -35.50% |
| 2023-04-01 | -33.80% |
| 2022-12-31 | -16.07% |
| 2022-10-01 | -13.56% |
| 2022-07-02 | -2.80% |
| 2022-04-02 | -3.00% |
| 2021-12-31 | 1.13% |
| 2021-10-02 | 3.70% |
| 2021-07-03 | 5.16% |
| 2021-04-03 | 5.73% |
| 2020-12-31 | 5.08% |
